These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9504042)

  • 1. What are the molecular mechanisms of neural tube defects?
    Corcoran J
    Bioessays; 1998 Jan; 20(1):6-8. PubMed ID: 9504042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3.
    Ting SB; Wilanowski T; Auden A; Hall M; Voss AK; Thomas T; Parekh V; Cunningham JM; Jane SM
    Nat Med; 2003 Dec; 9(12):1513-9. PubMed ID: 14608380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.
    Cogram P; Hynes A; Dunlevy LP; Greene ND; Copp AJ
    Hum Mol Genet; 2004 Jan; 13(1):7-14. PubMed ID: 14613966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants.
    Harris MJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):331-9. PubMed ID: 19117321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol prevents folate-resistant neural tube defects in the mouse.
    Greene ND; Copp AJ
    Nat Med; 1997 Jan; 3(1):60-6. PubMed ID: 8986742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects.
    Harris MJ; Juriloff DM
    Birth Defects Res A Clin Mol Teratol; 2007 Mar; 79(3):187-210. PubMed ID: 17177317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
    Harris MJ; Juriloff DM
    Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
    Shaw G
    Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):543. PubMed ID: 18428991
    [No Abstract]   [Full Text] [Related]  

  • 9. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure.
    Harris MJ; Juriloff DM
    Birth Defects Res A Clin Mol Teratol; 2010 Aug; 88(8):653-69. PubMed ID: 20740593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding the genetic basis of neural tube defects.
    Kibar Z; Capra V; Gros P
    Clin Genet; 2007 Apr; 71(4):295-310. PubMed ID: 17470131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of the neural tube defect mouse model bent tail is not sensitive to maternal folinic acid, myo-inositol, or zinc supplementation.
    Franke B; Klootwijk R; Lemmers B; de Kovel CG; Steegers-Theunissen RP; Mariman EC
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):979-84. PubMed ID: 14745918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
    Cavalli P; Tedoldi S; Riboli B
    Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):540-2. PubMed ID: 18418886
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse Fkbp8 activity is required to inhibit cell death and establish dorso-ventral patterning in the posterior neural tube.
    Wong RL; Wlodarczyk BJ; Min KS; Scott ML; Kartiko S; Yu W; Merriweather MY; Vogel P; Zambrowicz BP; Finnell RH
    Hum Mol Genet; 2008 Feb; 17(4):587-601. PubMed ID: 18003640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models of neural tube defects: investigating preventive mechanisms.
    Greene ND; Copp AJ
    Am J Med Genet C Semin Med Genet; 2005 May; 135C(1):31-41. PubMed ID: 15800852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology, pathogenesis and prevention of neural tube defects.
    Padmanabhan R
    Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis: folate-responsive neural tube defects and neurocristopathies.
    Antony AC; Hansen DK
    Teratology; 2000 Jul; 62(1):42-50. PubMed ID: 10861632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin and its receptor in the development of genetically determined neural tube defects in the mouse embryo.
    Hoyle C; Henderson DJ; Matthews DJ; Copp AJ
    Dev Dyn; 1996 Sep; 207(1):35-46. PubMed ID: 8875074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel changes in metabolite and expression profiles in crooked-tail mutant and folate-reduced wild-type mice.
    Ernest S; Carter M; Shao H; Hosack A; Lerner N; Colmenares C; Rosenblatt DS; Pao YH; Ross ME; Nadeau JH
    Hum Mol Genet; 2006 Dec; 15(23):3387-93. PubMed ID: 17050573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol, neural tube closure and the prevention of neural tube defects.
    Greene ND; Leung KY; Copp AJ
    Birth Defects Res; 2017 Jan; 109(2):68-80. PubMed ID: 27324558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.